Jodelle joined TriMed Media Group in 2016 as a senior writer, focusing on content for Radiology Business and Health Imaging. After receiving her master's from DePaul University, she worked as a news reporter and communications specialist.
Researchers from Case Western Reserve University School of Medicine and University Hospitals Cleveland Medical Center revealed in a new study that diagnostic MRI followed by one of three MRI-guided biopsy strategies could be a cost-effective detection method for prostate cancer.
According to Forbes, lung cancer is the leading cause of death in China. With thousands of people being affected, it is increasingly difficult for radiologists to examine hundreds of images each day with complete accuracy.
In a recent article published in the New York Law Journal, Andrew Kaufman, founding partner of Kaufman Borgeest & Ryan, outlines how to handle hindsight bias when it comes to defending radiology claims.
After collecting data from a group of parents, researchers from Harvard Pilgrim Health Care Institute found that almost two-thirds of parents agreed with policies to ban indoor tanning for those under the age of 18, due to risks including skin cancer.
To learn how smart our early tool-making ancestors were, an interdisciplinary research team is scanning the brains of modern humans to find out what kind of brainpower is needed to complete tool-making tasks.
The Have-A-Heart campaign has recently been launched by the Image Gently Alliance, the American Academy of Pediatrics (AAP) and a coalition of pediatric medicine and cardiology organization, addressing the issue of radiation safety in children with heart disease.
With highly complex medical documents greatly mismatched with patient literacy levels, a team of researchers set out to test a simplified “grade vs. length” readability metric developed based on results from factor analysis of 10 readability metrics applied to more than 500,000 radiology reports.
Advocates and lead researchers of Alzheimer’s disease published “Single Endpoint for New Drug Approvals for Alzheimer’s Disease,” urging the FDA to clarify and modernize its approach for approving new treatments.